Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Multiple sclerosis and cognitive decline: is ApoE-4 a surrogate marker?

Acta neurologica Scandinavica - 1 Oct 2011

Carmona O, Masuet C, Santiago O, Alía P, Moral E, Alonso-Magdalena L, Casado V, Arbizu T

Abstract excerpt

BACKGROUND - The role of the apolipoprotein E (ApoE) polymorphism has been well demonstrated in neurodegenerative disorders such as Alzheimer. However, its role in multiple sclerosis (MS) remains unclear. AIMS - The aims of our study were as follows: (i) to assess whether ApoE-4 might be a surrogate marker of cognitive decline in MS; (ii) to confirm the presence of cognitive impairment in mildly disabled patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoprotein E4
Share to Cognition Disorders
Share to Disability Evaluation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunologic Factors

Share to Interferon-beta

Share to Logistic Models

Share to Multiple Sclerosis, Relapsing-Remitting

Share to Neuropsychological Tests

Source

Identifiers

PMID: 21208197
DOI: 10.1111/j.1600-0404.2010.01473.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Multiple sclerosis and cognitive decline: is ApoE-4 a surrogate marker?PMID 21208197Read ↗

APOE epsilon 4 allele is associated with cognitive impairment in patients with multiple sclerosis.Semantic proximity Read ↗

The association of apolipoprotein E (ApoE) genotype and cognitive outcomes in multiple sclerosis; a systematic review and meta-analysis.Semantic proximity Read ↗

Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis.Semantic proximity Read ↗

APOE ε4 is associated with exacerbation of cognitive decline in patients with multiple sclerosis.Semantic proximity Read ↗

APOE epsilon4 and the cognitive genetics of multiple sclerosis.Semantic proximity Read ↗

ApolipoproteinE epsilon 4 allele is not associated with disease course and severity in multiple sclerosis.Semantic proximity Read ↗

Cognitive impairment in patients with multiple sclerosis: association with the APOE gene and promoter polymorphisms.Semantic proximity Read ↗

APOE and risk of cognitive impairment in multiple sclerosis.Semantic proximity Read ↗

APOE-epsilon4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis.Semantic proximity Read ↗

Apolipoprotein alleles and the response to interferon-β-1b in multiple sclerosis.Semantic proximity Read ↗

Apolipoprotein E (APOE) phenotype and APOE concentrations in multiple sclerosis and acute herpes zoster.Semantic proximity Read ↗

[Apolipoprotein E polymorphism as a predictor of progression of multiple sclerosis].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.